LivaNova (LIVN) Receivables - Other (2017 - 2025)
LivaNova (LIVN) reported Receivables - Other of $600000.0 for Q4 2025, down 81.82% on a YoY basis from $3.3 million in Q4 2024, and down 93.75% sequentially from $9.6 million in Q2 2025.
LivaNova (LIVN) Receivables - Other (2017 - 2025) Analysis & Trends
LivaNova (LIVN) has 3 years of Receivables - Other data on file, last reported at $600000.0 in Q4 2025.
- For the quarter ending Q4 2025, Receivables - Other fell 81.82% year-over-year to $600000.0; the trailing twelve-month figure through Dec 2025 stood at $600000.0 (down 81.82% YoY), and the FY2025 full-year result was $600000.0, down 88.24% from the prior year.
- Receivables - Other declined to $600000.0 in Q4 2025, from $9.6 million in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $9.6 million in Q2 2025 to a low of $100000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | LivaNova | 4.30 Bn | 3.76 Bn | 243.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 600,000.00 |
| Dec 31, 2025 | 600,000.00 |
| Jun 30, 2025 | 9.60 Mn |
| Jun 30, 2025 | 9.60 Mn |
| Mar 31, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 3.30 Mn |
| Dec 31, 2024 | 3.30 Mn |
| Sep 30, 2017 | 4.36 Mn |
| Sep 30, 2017 | 4.36 Mn |